High-risk non-melanoma skin cancer of the head and neck

Current Oncology Reports

Volumn 7, Issue 2, 2005, Pages 154-158

  Lai, Stephen Y ^a   Weber, Randal S ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; EFLORNITHINE; ETRETIN; IMIQUIMOD; SELENIUM;

CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CERVICAL LYMPH NODE; CLINICAL TRIAL; HEAD AND NECK CANCER; HIGH RISK POPULATION; HUMAN; METASTASIS; PAROTID GLAND; PHOTODYNAMIC THERAPY; RADIATION EXPOSURE; REVIEW; RISK FACTOR; SKIN CANCER; SURGICAL ANATOMY; SURGICAL APPROACH; SURGICAL TECHNIQUE; ULTRAVIOLET RADIATION; WART VIRUS;

EID: 16844383168     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-005-0042-9     Document Type: Review

References (35)

1. Kaldor J, Shugg D, Young B, et al.: Non-melanoma skin cancer: ten years of cancer-registry-based surveillance. Int J Cancer 1993, 53:886-891.
2. Padgett JK, Hendrix JJ: Cutaneous malignancies and their management. Otol Clin North Am 2001, 34:523-553.
3. Rowe D, Carroll RJ, Day CL Jr, et al.: Prognostic factors for local recurrence, metastasis and survival rates in squamous cell carcinoma of the skin, ear and lip: implications for treatment modality selection. J Am Acad Dermatol 1992, 26:976-990.
4. Goepfert H, Dichtel WJ, Medina JE, et al.: Perineural invasion of squamous cell skin carcinoma of the head and neck. Am J Surg 1984, 148:542-547.
5. Johnson T, Rowe DE, Nelson BR, et al.: Squamous cell carcinoma of the skin (excluding lip and oral mucosa). J Am Acad Dermatol 1992, 26:467-484.
6. Urbach F: Ultraviolet radiation and skin cancer of humans. J Photochem Photobiol 1997, 40:3-7.
7. Ananthaswamy HN, Pierceall PW: Molecular mechanisms of ultraviolet radiation carcinogenesis. Photochem Photobiol 1990, 52:1119-1136.
8. Buzzell RA: Carcinogenesis of cutaneous malignancies. Dermatol Surg 1996, 22:209-215.
9. Buzzell RA: Effects of solar radiation of the skin. Otolaryngol Clin North Am 1993, 26:1-11.
10. Harwood C, Surentheran T, McGregor JM, et al.: Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 2000, 61: 89-297.
11. Proby C, Storey A, McGregor J, et al.: Does human papillomavirus play a role in non-melanoma skin cancer? Papillomavirus Rep 1996, 7:53-60.
12. Iftner A, Klug SJ, Garbe C, et al.: The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimunosuppressed individuals identifies high-risk genital types as possible risk factors. Can Res 2003, 63:7515-7519.
13. Jensen P, Hansen S, Moller B, et al.: Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999, 40:177-186.
14. Veness M, Quinn DI, Ong CS, et al.: Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience. Cancer 1999, 85:1758-1764.
15. Westra W, Kronz JD, Eisele DW: The impact of second opinion surgical pathology on the practice of head and neck surgery: a decade experience at a large referral hospital. Head Neck 2002, 24:684-693.
16. Garcia-Serra A, Hinerman RW, Mendenhall WM, et al.: Carcinoma of the skin with perineural invasion. Head Neck 2003, 25:1027-1033.
17. del Charco J, Mendenhall WM, Parsons JT, et al.: Carcinoma of the skin metastatic to the parotid area lymph nodes. Head Neck 1998, 20:369-373.
18. Chu A, Osguthorpe JD: Nonmelanoma cutaneous malignancy with regional metastasis. Otolaryngol Head Neck Surg 2003, 128:663-673.
19. Lai S, Weinstein GS, Chalian AA, et al.: Parotidectomy in the treatment of aggressive cutaneous malignancies. Arch Otolaryngol Head Neck Surg 2002, 128:521-526.
20. O'Brien CJ, McNeil EB, McMahon JD, et al.: Incidence of cervical node involvement in metastatic cutaneous malignancy involving the parotid gland. Head Neck 2001, 23:744-748.
21. O'Brien CJ, McNeil EB, McMahon JD, et al.: Significance of clinical stage, extent of surgery and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland. Head Neck 2002, 24:417-422.
22. Wagner J, Evdokimov DZ, Weisberger E, et al.: Sentinel node biopsy for high-risk nonmelanoma cutaneous malignancy. Arch Dermatol 2004, 140:75-79.
23. Michl C, Starz H, Bachter D, et al.: Sentinel lymphadenectomy in nonmelanoma skin malignancies. Br J Dermatol 2003, 149:763-769.
24. Finks-Puchs R, Soyer HP, Hofer A, et al.: Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy. Arch Dermatol 1998, 134:821-826.
25. Marks R, Gebauer K, Sumack S, et al.: Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial. J Am Acad Dermatol 2001, 44:807-813.
26. Nouri K, O'Connell C, Rivas MP: Imiquimod for the treatment of Bowen's disease and invasive squamous cell carcinoma. J Drugs Dermatol 2003, 2:669-673.
27. Hennge U, Schaller J: Successful treatment of invasive squamous cell carcinoma using topical imiquimod. Arch Dermatol 2004, 140:404-406.
28. Nguyen TH, Ho DQ: Nonmelanoma skin cancer. Curr Treat Options Oncol 2002, 3:193-203.
29. Wolf R, Tuzun B, Tuzun Y: Sunscreens. Dermatol Ther 2001, 14:208-214.
30. DeBuys H, Levy SB, Murray JC, et al.: Modern approaches to photoprotection. Dermatol Surg 2000, 18: 77-590.
31. Bickers D, Athar M: Novel approaches to chemoprevention of skin cancer. J Dermatol 2000, 27:691-695.
32. Stratton S, Dorr RT, Alberts DS: The state-of-the-art in chemoprevention of skin cancer. Eur J Cancer 2000, 36: 292-1297.
33. Alberts D, Dorr RT, Einspahr JG, et al.: Chemoprevention of human actinic kerotoses by topical 2-(difluoromethyl)-d-ornithine. Cancer Epidemiol Biomark Prev 2000, 9:1281-1286.
34. Einspahr J, Nelson MA, Saboda K, et al.: Modulation of biologic endpoints by topical difluoromethylornithine (DFMO), in subjects at high-risk for nonmelanoma skin cancer. Clin Can Res 2002, 8:149-155.
35. Duffield-Lillico A, Slate EH, Reid ME, et al.: Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial. J Natl Cancer Inst 2003, 95: 477-1481.